Eliglustat 2 mg | 99.71%
TargetMol
Eliglustat is an oral inhibitor of glucosylceramide synthase which is used in the therapy of type 1 Gaucher disease.
More Information Supplier PageEliglustat
Search Results
Olivetol 100 mg | 99.74%
TargetMol
Olivetol (5-pentylresorcinol, 5-pentyl-1,3-benzenediol) is an organic compound found in certain species of lichen; it is also a precursor in various syntheses of tetrahydrocannabinol. Olivetol has an antioxidant effect.
More Information Supplier PageOlivetol
SR9011 25 mg | 99.60%
TargetMol
SR9011 is a REV-ERB agonist (IC50: 790 nM, REV-ERBα; IC50: 560 nM, REV-ERBβ).
More Information Supplier PageSR9011
SR9011 1 mg | 99.60%
TargetMol
SR9011 is a REV-ERB agonist (IC50: 790 nM, REV-ERBα; IC50: 560 nM, REV-ERBβ).
More Information Supplier PageSR9011
1-Deoxynojirimycin 100 mg | 99.82%
TargetMol
1-Deoxynojirimycin is a potent α-glucosidase inhibitor, suppressing postprandial blood glucose, thereby possibly preventing diabetes mellitus.
More Information Supplier Page1-Deoxynojirimycin
1-Deoxynojirimycin 2 mg | 99.82%
TargetMol
1-Deoxynojirimycin is a potent α-glucosidase inhibitor, suppressing postprandial blood glucose, thereby possibly preventing diabetes mellitus.
More Information Supplier Page1-Deoxynojirimycin
Eliglustat 100 mg | 99.71%
TargetMol
Eliglustat is an oral inhibitor of glucosylceramide synthase which is used in the therapy of type 1 Gaucher disease.
More Information Supplier PageEliglustat
Paritaprevir 100 mg | 99.57%
TargetMol
Paritaprevir is an orally bioavailable, synthetic acylsulfonamide inhibitor of the hepatitis C virus (HCV) protease complex comprised of non-structural protein 3 and 4A (NS3/NS4A), with potential activity against HCV genotype 1. Upon administration, paritaprevir reversibly binds to the active center and binding site of the HCV NS3/NS4A protease and prevents NS3/NS4A protease-mediated polyprotein maturation. This […]
More Information Supplier PageParitaprevir
Paritaprevir 200 mg | 99.57%
TargetMol
Paritaprevir is an orally bioavailable, synthetic acylsulfonamide inhibitor of the hepatitis C virus (HCV) protease complex comprised of non-structural protein 3 and 4A (NS3/NS4A), with potential activity against HCV genotype 1. Upon administration, paritaprevir reversibly binds to the active center and binding site of the HCV NS3/NS4A protease and prevents NS3/NS4A protease-mediated polyprotein maturation. This […]
More Information Supplier PageParitaprevir
PF3274167 25 mg | Purity Not Available
TargetMol
PF-3274167 is a potent and selective, high-affinity nonpeptide oxytocin receptor antagonist.
More Information Supplier PagePF3274167
